According to FutureWise analysis the market for Corneal Implant in 2023 was US$ 1.34 billion, and is expected to reach US$ 2.05 billion by 2031 at a CAGR of 5.50%.
Corneal Implant is a step that is between contact lenses and a corneal transplant. Corneal implants are mainly used for the treatment of keratoconus, it’s a degenerative disorder of the eye in which the cornea thins and becomes a more conical shape rather than a normal gradual curve. Corneal implants are designed for long term vision with numerous advantages includes outpatient procedure, less invasive than a corneal transplant. There are different types of corneal implants are available which includes refractive corneal implants, corneal reshaping, and small aperture implants.
Increasing prevalence of corneal ulcers, infection, and keratoconus is expected to boost the growth of the market. Additionally, increasing incidence of genetic disorders like fuch’s dystrophy is expected to fuel the growth. Further, increasing adoption of corneal transplantation in primary healthcare settings and awareness among the general population is expected to boost the growth of corneal implant market. Along with this, increased per capita healthcare expenditure of the general population is expected to increase the adoption of implants. Recent advances in medical technologies further decreased the complication of traditional methods and improved adoption. It also decreased medical errors and increased the success rate of transplantation.